Ebola Vaccine - I've Been Through It Multiple Times, Zika Multiple Times

The DoD had asked him to intervene with a company called New Link Genetics that had purchased for $150,000 this product candidate from Canada. I did a threat assessment, made a decision that there was no way to develop a vaccine in time to really mitigate the risk. And I needed to focus on drug repurposing and that's what I did and focused on. There's a whole backstory with Pierre Corey and Iver Mechtin and starting a journal volume in frontiers for repurposed drugs that then got shut down.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app